Home / Markets / KNSA / Balance Sheet ← All companies K Kiniksa Pharmaceuticals, Ltd. KNSA - CIK 0001730430
Overview Market Cap Revenue Net Income Income Statement Balance Sheet Cash Flow SEC Filings KNSA balance sheet (quarterly) The table below shows Kiniksa Pharmaceuticals, Ltd.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item Q1 2026 Q3 2025 Q2 2025 Q1 2025 Q3 2024 Q2 2024 Cash & equivalents $189.95M $174.86M $192.04M $157.13M $97.38M $99.27M Short-term investments $278.14M $177.24M $115.75M $111.21M $126.40M $119.49M Receivables $23.22M $51.74M $31.91M $40.06M $24.89M $20.45M Inventory $73.14M $41.40M $48.18M $22.07M $28.68M $34.86M
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings .